Translation and mRNA degradation are affected by a key transition where eukaryotic mRNAs exit translation and assemble an mRNP state that accumulates into processing bodies (P bodies), cytoplasmic sites of mRNA degradation containing nontranslating mRNAs, and mRNA degradation machinery. We identify the decapping activators Dhh1p and Pat1p as functioning as translational repressors and facilitators of P body formation. Strains lacking both Dhh1p and Pat1p show strong defects in mRNA decapping and P body formation and are blocked in translational repression. Contrastingly, overexpression of Dhh1p or Pat1p causes translational repression, P body formation, and arrests cell growth. Dhh1p, and its human homolog, RCK/p54, repress translation in vitro, and Dhh1p function is bypassed in vivo by inhibition of translational initiation. These results identify a broadly acting mechanism of translational repression that targets mRNAs for decapping and functions in translational control. We propose this mechanism is competitively balanced with translation, and shifting this balance is an important basis of translational control.
Introduction
A key aspect of the regulation of eukaryotic gene expression is control of mRNA translation and degradation. A major pathway of mRNA decay in eukaryotes is initiated by shortening of the 3# poly(A) tail (deadenylation), followed by cleavage of the 5# m7 GpppN cap (decapping), and ultimately, 5# to 3# exonucleolytic degradation (for review, see Coller and Parker, 2004) . Decapping is a critical step in this decay pathway as it permits destruction of the mRNA body and is a site of numerous control inputs. Translation and mRNA decapping are intertwined. For example, decreasing translation initiation by a variety of means increases the rate of decapping. Conversely, inhibition of translation elongation significantly decreases the rate of decapping (Coller and Parker, 2004) . Moreover, translation initiation factors such as the cap binding protein eIF-4E can directly inhibit decapping, and thus before an mRNA undergoes decapping, it exits translation by an unknown mechanism wherein translational initiation factors dissociate from the transcript, and an mRNA de- The requirement for exiting translation prior to decapping implies that there is a general, and unknown, process by which the vast majority of mRNAs can exit translation and enter a translationally inactive state. In principle, exiting of mRNAs from translation could simply be a passive process occurring in the absence of ongoing recruitment of the translational apparatus. In this view, translational repression would occur as a default state. Alternatively, and more consistent with mRNA decapping being a regulated process, the cell may possess a general mechanism for actively targeting mRNAs into a translationally repressed state.
Evidence suggesting cells might have a general mechanism for translational repression comes from the observation that mRNAs that have exited translation and can be targeted for decapping, accumulate within discrete cytoplasmic foci, referred to as P bodies (also referred to as GW182 or DCP bodies). P bodies are dynamic RNA-protein aggregates containing untranslated mRNAs, the decapping machinery (Bashkirov et al. . This suggests that when mRNAs exit translation, they assemble an mRNP complex containing the decapping machinery, which can then undergo either decapping, or aggregation into P bodies. It is currently unclear whether assembly of individual mRNPs into a larger P body structure directly affects the rate of decapping or plays a different role in control of mRNA function.
An important and unresolved issue is the manner by which mRNAs exit translation and are targeted for decapping and accumulation in P bodies. Moreover, because P bodies increase under conditions that globally repress translation, it is possible that the mechanism that targets mRNAs for decapping and P body accumulation might also play an important role in the control of translation, both globally and on specific mRNAs.
Given the intertwined nature of mRNA decapping and translation, we hypothesized that a subset of the proteins involved in decapping may function by promoting translational repression. Indeed, several observations led us to hypothesize that the decapping activators, Dhh1p, and Pat1p might function in the pathway of moving mRNAs from polysomes and into the translationally inert state that accumulates in P bodies. In this work, we tested this hypothesis by examining the functions of Dhh1p and Pat1p with respect to mRNA decay, P body formation, and translational repression. Our results indicate that Dhh1p and Pat1p function as a general and active mechanism of translational repression, which functions independent of the cap structure and can also repress translation from a broad spectrum of IRES elements. This translational repression machinery targets mRNAs for decapping, facilitates their assembly into P bodies, and appears to be conserved throughout eukaryotes. Importantly, these results indicate that a general translation repression machinery exists within cells that is in constant competition with the translation apparatus and that the balance of this competition provides the basis for translational repression that occurs under numerous biological contexts.
Results

Dhh1p and Pat1p Have Additive Effects on mRNA Decay
As discussed above, we hypothesized that the decapping regulators, Dhh1p, and Pat1p might function independently in the pathway of moving mRNAs from polysomes and into the translationally inert state that accumulates in P bodies. To test this hypothesis, we first examined the phenotypes of dhh1D, pat1D, and dhh1D/pat1D double mutants, with respect to mRNA decay, P body formation, and translational repression. In addition, because the Lsm1-7p complex can also promote mRNA decapping, we examined the effects of combining a lsm1D, which inactivates the Lsm1-7p complexes function in mRNA decapping, with the pat1D and dhh1D lesions.
The effect of each mutant background on decapping was determined by using a transcriptional shut-off strategy for the MFA2pG reporter gene, which is under the control of the GAL promoter, thereby allowing repression of transcription by addition of glucose (Muhlrad et al., 1994). In addition, the MFA2pG gene contains a polyguanosine tract (pG) in its 3#UTR that blocks 5# to 3# exonuclease digestion and thereby traps an intermediate in mRNA degradation (Muhlrad et al., 1994) .
We observed that dhh1D/pat1D double mutants had a severe block to mRNA decapping, stronger than either dhh1D or pat1D single mutants. Specifically, following glucose repression of transcription, decay rate of the MFA2pG mRNA is slowed in dhh1D (t 1/2 = 12#; Figure S1B in the Supplemental Data available with this article online) or pat1D (t 1/2 = 15#; Figure S1C ) compared to wild-type (WT) (t 1/2 = 5#; Figure S1A ), whereas the dhh1D/pat1D strain shows an even slower decay rate (t 1/2 = 26#; Figure S1D ). Accumulation of stable, deadenylated mRNAs in dhh1D/pat1D indicates a significant defect in mRNA decapping ( Figure S1D The strong block to mRNA decapping seen in dhh1D/ pat1D could be a result of either an inability to exit translation and thus access the decapping machinery (decreasing P body abundance) or an inability to be processed by the decapping enzyme (increasing P body abundance). To distinguish between these two possibilities, we monitored P body formation in dhh1D, pat1D, and dhh1D/pat1D strains under glucose deprivation, which stimulates P body formation (Teixeira et al., 2005) . Visualization of P bodies was achieved using a GFP fusion protein of the decapping enzyme Dcp2p Figure 1A, panel i) . In both dhh1D and pat1D, the number of P bodies did not change significantly ( Figure 1A , panel ii and iii). However, in dhh1D/pat1D, less than 10% of cells contained P bodies ( Figure 1A, panel iv) . This is in contrast to a dcp1D strain, which lacks a component of the decapping enzyme, thus inhibiting the decapping reaction directly and causing P bodies to accumulate (Sheth and Parker, 2003) ( Figure 1A, panel v) . These strains all contained similar levels of the Dcp2p-GFP protein, indicating that differences in P body abundance were not due to decreased expression of the fusion protein ( Figure  S2A ). Additionally, changes in P body size and abundance are not reflective of growth rate differences as dhh1D/pat1D grows similarly to the dcp1D strain. Furthermore, similar results were obtained by monitoring P bodies using a GFP fusion to Lsm1p ( Figure S3 ). Together, these results argue that Dhh1p and Pat1p act at an early step in mRNA decay prior to P body formation. Since translational repression is a key step in promoting mRNA decapping Parker, 1999, 2000) The ability of Dhh1p to repress translation in both yeast and mammalian cell extracts suggested that this function would be conserved in its homologs. To test this prediction, we purified the human homolog of Dhh1p, termed RCK/p54, and examined if it could repress translation in vitro. Similar to Dhh1p, recombinant RCK/p54 repressed LUC translation in a dose-dependent manner ( Figure 4D ). These results demonstrate that Dhh1p can directly repress translation and this function is conserved from yeast to mammals.
Dhh1p Inhibits the Production of a Stable 48S Preinitiation Complex
Recapitulation of Dhh1p-dependent translational repression in vitro facilitated examination of the mechanism by which Dhh1p affects translation. Translational initiation can be divided into three broad steps. First, eIF-4F recognizes and binds the 5#-cap structure. Second, eIF-4F, with eIF3, recruits 43S preinitiation complex (consisting of the 40S ribosome, eIF2, GTP, and Met-tRNA i ), leading to formation of a 48S preinitiation complex. Third, 48S complex recognizes the AUG, at which point GTP is hydrolyzed and the 60S ribosomal subunit joins, initiating polypeptide synthesis.
It has previously been proposed that Dhh1p might act to dissociate eIF-4E from the 5#-cap structure and thereby promote decapping (Fischer and Weis, 2002) . Such a mode of function could also explain Dhh1p's inhibition of translation. If Dhh1p acts to dissociate eIF-4E from the cap structure than Dhh1p would be predicted to have no effect on the translation of uncapped mRNAs. However, we observed that both Dhh1p and RCK/p54 were equally effective at repressing the translation of both capped and uncapped mRNAs ( Figure 4E and data not shown). This argues that Dhh1p inhibits a step in translation independent of cap recognition.
To determine if Dhh1p affects a step upstream of formation of 48S preinitiation complex, translation extracts were programmed with radiolabeled mRNA with or without Dhh1p and in the presence of various translational inhibitors. Use of substeps specific inhibitors allows translational initiation to be studied by trapping dynamic intermediates (Gray and Hentze, 1994). Accumulation of initiation complexes was monitored by sucrose density gradient sedimentation and quantification of labeled mRNA following fractionation. In WT cells, addition of a nonhydrolysable GTP analog (GMPPNP) blocks 60S subunit joining causing accumulation of 48S preinitiation complex ( Figure 4F ) (Gray and Hentze, 1994) . Strikingly, addition of purified Dhh1p eliminated accumulation of 48S preinitiation complex ( Figure 4F ). This result suggests that Dhh1p represses translation in vitro by inhibiting the ability of 48S complex to form on mRNA. These effects may be a direct consequence of Dhh1p acting upstream of 48S formation, acting on the 48S complex itself, or via promotion of assembly of a repression complex that is independent of translational initiation factors.
Broad Spectrum Inhibition of mRNA Translation by Dhh1p and RCK/p54
To determine if Dhh1p or RCK/p54 affect a specific step in translation initiation or were broadly acting general translational repressors, we examined their effect on translational initiation driven by various internal ribosomal entry sites (IRES). IRES elements allow translational initiation in a manner independent of subsets of translation initiation factors ( Figure 5A ). This allows translation inhibitors that act on discrete translational initiation factors to have their site of action identified (Ostareck et al., 2001 ). We focused on RCK/p54 for these experiments as IRES elements function more efficiently in mammalian systems and used IRES elements 
Translational Initiation Is Required for Dhh1p Effects In Vivo
If Dhh1p is a translational repressor, then we predicted that blocking translation by a strong stem-loop in the 5#UTR would bypass Dhh1p function in vivo (Muhlrad et al., 1995) . We observed that the PGK1 mRNA bearing a stem-loop in the 5#UTR (SL-PGK1) decays rapidly in wild-type cells (t 1/2 = 5.4#; Figure 6A ). Importantly, decay of the SL-PGK1 was not affected in dhh1D strains Figures 1 and 2) . Second, overexpression of either Pat1p or Dhh1p inhibits growth, decreases polysomes, and drives P body accumulation ( Figures 3A, 3B, and  3D) . Third, Dhh1p and its human homolog RCK/p54 function as translation repressors in vitro ( Figure 4D) . Fourth, inhibiting translational initiation in cis bypasses Dhh1p function in vivo (Figure 6 ). These results document that Dhh1p and Pat1p, which had been characterized as activators of the mRNA decapping reaction, function at least in part to repress translation and facilitate the transition in mRNP organization that leads to mRNAs being subject to decapping. One anticipates that other activators of decapping will also function by inhibiting translation. For example, mRNAs targeted for decapping by nonsense-mediated decay are also translationally repressed in a manner dependent upon Upf1p (Muhlrad and Parker, 1999), which suggests that Upf1p will act as a repressor of translation in some manner.
There are two possible mechanisms by which Dhh1p might inhibit translation. In the simplest model, Dhh1p might promote the assembly of a translation repression complex, which sequesters the mRNA into an mRNP that is unable to be accessed by translation initiation factors. Thus, translation repression occurs by sequestration of the mRNA away from the translation machinery. Consistent with this hypothesis. Dhh1p accumulates within P bodies in conjunction with translationally repressed mRNAs (Teixeira et al., 2005) . Because Dhh1p is a member of the DEAD box family of "RNA-helicases," Dhh1p could utilizes the energy of ATP hydrolysis, coupled with RNA binding, to create an irreversible step in assembly that commits an mRNA to the translationally repressed state. Such an mRNP rearrangement may facilitate further association and aggregation of the repression complex, thereby creating a cascade of events that sequester the mRNA into a quiescent mRNP particle, such as a P body. Alternatively, Dhh1p may interact with and inhibit the function of a required translation factor. However, if Dhh1p works in this manner, its inhibition of 48S complex for- (Figures 2A-2C) . Fourth, RCK/p54 represses translation of all mRNAs tested in vitro indicating the effects are not specific to the cap, poly(A) tail, or a specific initiation step (Figures 4D and 5B) . Thus, these results identify a general mechanism of translational repression that can The presence of this active repression machinery suggests that the status of translation, both globally and on specific mRNAs, is due to the constant competition between the translational machinery and the repression machinery (Figure 7 ). For example, in the absence of Dhh1p and Pat1p, global translation is only marginally impaired by glucose deprivation or amino acid starvation. This argues that the decrease in translation caused by these stresses is only sufficient to repress translation when there is a competing mechanism to sequester the mRNAs in a repressed state (Figures 1B and 1E ). This suggests that the translation and repression mechanisms are finely balanced, and relatively subtle alterations in function of either may have profound consequences for the distribution of mRNAs between translation and repression.
The generality of Dhh1p and Pat1p translational repression suggests that translation and decay are fundamentally coupled because the mode of translational repression that accesses decapping is a major mode of general translational repression. This provides an explanation for the observation that numerous cis-acting sequences controlling mRNA decay also affect translational repression. For example, the AU-rich destabilizing elements, referred to as AREs, often found in unstable metazoan mRNAs, can serve as translational repression elements in some biological contexts (Otero et al., 2001) . Similarly, cis-acting elements in mRNAs important for Drosophila development can modulate both decay and translation (Sonoda and Wharton, 1999) . A simple model is that some of these control elements recruit translational repressors, possibly Dhh1p or Pat1p, which then promote mRNAs exiting translation. Because there are clearly additional steps in the decay pathway before decapping actually occurs, the context of the translational repression could lead either to translational repression and mRNA storage or to mRNA degradation.
The competition between assembly of a translation complex and repression suggests the translation rate of individual mRNAs can be consequence of its relative ability to either assemble translation factors or interact with various components of the repression machinery. Thus, an mRNP that effectively recruits the repression complex may strongly shift an mRNA into the repressed state. In addition, several observations suggest mRNAspecific repression complexes might feed into the general repression system we have described. For example, in Drosophila, the Oskar mRNA assembles a tripartite complex wherein eIF-4E is bound to the cap, but prevented from interaction with eIF-4G by the eIF-4E binding protein Cup, which is delivered to the mRNA by an interaction with the sequence specific binding of More recently, the demonstration that mRNAs translationally repressed by miRNAs accumulate in P bodies suggests that miRNA based translational repression might also interact with this general translation repression machinery (Liu et al., 2005) . These interactions suggest that mRNA-specific translational repression mechanisms might create an initial translationally repressed mRNP, which then either directly or indirectly interacts with the general translational repression machinery to create a multilayered and robust system of translational control.
Conclusion
The general system of translational repression described here provides a mechanistic understanding into the interwoven nature of translation and mRNA decay. Since movement of an mRNA into translational repression stimulates assembly of the decapping complex, shifting the balance toward assembly of the translational repression complex will, in many cases, facilitate removal of the mRNA from the cytoplasmic pool by decapping and thus maintain a linear movement of mRNA from translation to repression to decay. In cases where decapping is inhibited, either globally or in a mRNAspecific manner, movement between translation and repression might occur interchangeably and presumably in a regulated fashion to control protein production.
Importantly, the presence of a general active mechanism of translational repression implies the translation status of a cytoplasmic mRNA is the consequence of a constant competition between the translational apparatus and the repression apparatus. This is analogous to regulation of gene expression by alterations in chromatin states, where shifting DNA from chromatin to heterochromatin impacts transcription by driving and maintaining active and inactive states. Analogously, the general translational repression machinery we describe creates an inactive mRNP state, with formation of a P body being the ultimate manifestation of this event. The key switch that stimulates the shift from translation to repression could be any number of events, including attenuation of the translational machinery, deadenylation, activation of the repression machinery, or specific recruitment of the repression complex. While the repression machinery may be ultimately what tips the scale toward inactivation, it may be sequestration of mRNA into a P body that, much like sequestration of DNA into heterochromatin, maintains the repression event, thereby limiting reentry of mRNA into translation.
Experimental Procedures
Yeast Strains, Plasmids, and Oligonucleotides See Table S1 . Figures 1B and 1E , cells were grown in 2% dex media, harvested, and resuspended in either media plus or minus dex (Figure 2B) , or plus or minus amino acids ( Figure 2E ) and incubated for 10 min. In Figures 2A, 3B , and 3C, cells were grown in 2% suc media, harvested, and resuspended in 2% suc or 2% gal media. Cultures were incubated for 120 min. and then harvested. Figure  4F cells were grown in 2% dex media, and polysomes were analyzed using 7%-47% sucrose gradients. In Figure 4F , a 5%-25% gradient was used. 
RNA Analysis
In Vivo Labeling
Microscopy
For Figures 1A, 2A, 3B, 3C , and S3, P bodies were visualized with pRP1175 (DCP2-GFP) or pRP1176 (LSM1-GFP). In Figure 1A , cells were grown in 2% dex media until OD 600 = 0.3. Cells were harvested in media lacking glu and visualized by microscopy. In Figures 2A, 3B , and 3C, cells were grown to OD 600 = 0.3 in 2% suc media and resuspended in either 2% suc or 2% gal media and visualized after 120 min.
Western Blot Analysis
Protein analysis was performed as described in Sheth and Parker (2003), using anti-GFP antibody (Covance). In Figures 4A-4D, 250 ng of capped, poly(A) -LUC mRNA was added to each reaction. Extracts were programmed with 250 ng of capped or uncapped LUC mRNA ( Figure 4E ) or 250ng of IRES mRNA ( Figure 5B) . In Figure 4F, 1 g of radiolabeled,  capped, poly(A) -mRNA was used plus 0.5mM GMPPNP. Reactions were assembled and incubated 1 hr at 30°C for retic or 22°C yeast extract experiments. In Figures 4A-4E and 5B, LUC expression was monitored using a LUC enzymatic assay (Promega). In Figure 4F , translation was monitored by sucrose gradient, using a 5%-25% gradient followed by Scintillation counting after fractionation.
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